A Randomized, Double-blind, Single-dose, Parallel Two-arm Study to Compare the Pharmacokinetics and Safety of BAT1706 Injection From Different Manufacturing Batches (by New Process and Old Process) in Healthy Subjects
Latest Information Update: 22 May 2023
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer; Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Biothera
Most Recent Events
- 22 May 2023 New trial record